US-based medical device company St. Jude Medical has introduced its Infinity Deep Brain Stimulation (DBS) System and directional DBS lead in Europe to treat patients with Parkinson's disease, tremor and dystonia.
The Infinity DBS system generates mild electrical pulses to specific targets in the brain to stimulate the structures responsible for motor control.
It enables physicians to accurately deliver the impulse through the DBS system.
St. Jude Medical's new directional lead uses eight independent electrodes for a precise delivery of the stimulation enabling the physicians to specifically direct the impulse to targeted structures and areas of the brain.
The technology allows physicians to customise the therapy in accordance to the patient's specific needs while avoiding unnecessary stimulation to areas that may lead to side effects.
St. Jude Medical medical affairs vice-president and neuromodulation medical director Dr. Allen Burton said: "The Infinity DBS system and directional lead design was designed to meet the needs of physicians who confirmed that they needed a system that prioritised improved stimulation targeting, device longevity and improved patient ease of use.
"The Infinity DBS system is our answer for these previously unmet needs, demonstrating St. Jude Medical's commitment to patient-centric solutions that help alleviate the debilitating effects of movement disorders."
The Infinity system is made available in two different sizes to address patient comfort and is a maintenance-free and durable recharge-free system.
It caters to the patient controller and physician programmers by using bluetooth wireless technology and Apple digital devices.
Additionally, the St. Jude Infinity system can also be upgraded, which provides access to advanced technology for the patients without the need of repetitive surgery.
Image: St. Jude Medical's Infinity DBS system. Photo: courtesy of St. Jude Medical.